Literature DB >> 9722067

Long-term effects of allogeneic bone marrow transplantation (BMT) on pituitary, gonad, thyroid and adrenal function in adults.

M Kauppila1, P Koskinen, K Irjala, K Remes, J Viikari.   

Abstract

To evaluate the late-effects of allogeneic bone marrow transplantation (BMT) on endocrine function 20 adults (10 females, 10 males) with hematological malignancies were studied after a mean of 3.2 years (range 1.0-10.0) following BMT. The mean age of patients at the time of BMT was 39 years. Dynamic tests of the hypothalamic-pituitary axis included growth hormone releasing hormone (GHRH), gonadotropin releasing hormone (GnRH) and thyrotropin releasing hormone (TRH) stimulations with measurements of serum growth hormone (GH), follicle stimulating hormone (FSH), luteinizing hormone (LH), thyrotropin (TSH) and prolactin (PRL) responses. Adrenal function was assessed with the adrenocorticotropin (ACTH) test. Five patients (25%) had a subnormal GH response to GHRH stimulation, but all had a normal serum insulin-like growth factor I (IGF-I) value. There was an inverse nonlinear relationship between the body mass index (BMI; kg/m2) and GH response but no relation between the GH response and total body irradiation (TBI), intrathecal treatment or occurrence of graft-versus-host disease. In females, serum FSH and LH basal levels and responses to GnRH, in spite of oestrogen substitution therapy in 9/10 patients, indicated ovarian failure and early menopause. Most responses to GnRH were delayed. All males had elevated serum basal FSH levels indicating damage in seminiferous tubulus and infertility. Serum basal LH was elevated only in four males but testosterone values were all within normal limits. However, the mean free androgen index (FAI) was in the low normal range, and two subjects had abnormally low FAI. Serum free thyroxine (fT4) levels were normal in all but one, but an exaggerated TSH response to TRH occurred in seven patients (35%). Four of them had received TBI and one total nodal irradiation suggesting radiation-induced damage to the thyroid gland. In 19 of the 20 patients, adrenal function judged with ACTH test was normal. We conclude that functional impairments of the hypothalamus-pituitary-gonad/thyroid axis are common while disturbances in GH, adrenal and prolactin occur less often in patients after intensive treatment and BMT. Typically, the target organ is more commonly affected than the hypothalamus-pituitary axis. In spite of normal serum testosterone and LH values, serum FAI may reveal androgen deficiency.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9722067     DOI: 10.1038/sj.bmt.1701337

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  13 in total

1.  Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation.

Authors:  Sogol Mostoufi-Moab; Jill P Ginsberg; Nancy Bunin; Babette S Zemel; Justine Shults; Meena Thayu; Mary B Leonard
Journal:  J Pediatr       Date:  2011-08-11       Impact factor: 4.406

Review 2.  The immune system as a regulator of thyroid hormone activity.

Authors:  John R Klein
Journal:  Exp Biol Med (Maywood)       Date:  2006-03

Review 3.  Long-term follow-up after allogeneic stem cell transplantation.

Authors:  Inken Hilgendorf; Hildegard Greinix; Jörg P Halter; Anita Lawitschka; Hartmut Bertz; Daniel Wolff
Journal:  Dtsch Arztebl Int       Date:  2015-01-23       Impact factor: 5.594

4.  Metabolic syndrome in hematologic malignancies survivors: a meta-analysis.

Authors:  Chunyan Li; Pengcheng Liu; Lu Liu; Xiaoli Zhang; Peng Yang; Hui Sheng; Le Bu; Hong Li; Shen Qu
Journal:  Med Oncol       Date:  2014-12-04       Impact factor: 3.064

Review 5.  Sex-Specific Cardiovascular Risks of Cancer and Its Therapies.

Authors:  Nicholas S Wilcox; Seth J Rotz; McKay Mullen; Evelyn J Song; Betty Ky Hamilton; Javid Moslehi; Saro H Armenian; Joseph C Wu; June-Wha Rhee; Bonnie Ky
Journal:  Circ Res       Date:  2022-02-17       Impact factor: 17.367

6.  Sexual function changes during the 5 years after high-dose treatment and hematopoietic cell transplantation for malignancy, with case-matched controls at 5 years.

Authors:  Karen L Syrjala; Brenda F Kurland; Janet R Abrams; Jean E Sanders; Julia R Heiman
Journal:  Blood       Date:  2007-09-18       Impact factor: 22.113

7.  Sexuality after hematopoietic stem cell transplantation.

Authors:  Jean C Yi; Karen L Syrjala
Journal:  Cancer J       Date:  2009 Jan-Feb       Impact factor: 3.360

8.  Endocrine complications after busulphan and cyclophosphamide based hematopoietic stem cell transplant: A single tertiary care centre experience.

Authors:  Abhay Gundgurthi; M K Garg; Velu Nair; Rajeev Pakhetra; Satyanarayan Das; Sanjeevan Sharma; Manoj K Dutta; Sandeep Kharb; Rajan Kapoor
Journal:  Indian J Endocrinol Metab       Date:  2013-09

9.  Diabetes mellitus among cancer survivors.

Authors:  Charles J Stava; Martha L Beck; Lei Feng; Adriana Lopez; Naifa Busaidy; Rena Vassilopoulou-Sellin
Journal:  J Cancer Surviv       Date:  2007-06       Impact factor: 4.062

10.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.